Applied DNA Sciences Inc
NASDAQ:BNBX

Watchlist Manager
Applied DNA Sciences Inc Logo
Applied DNA Sciences Inc
NASDAQ:BNBX
Watchlist
Price: 1.57 USD -5.99% Market Closed
Market Cap: 6.8m USD

Operating Margin

-406.1%
Current
Declining
by 166.8%
vs 3-y average of -239.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-406.1%
=
Operating Income
$-13.4m
/
Revenue
$3.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-406.1%
=
Operating Income
$-13.4m
/
Revenue
$3.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Applied DNA Sciences Inc
NASDAQ:APDN
4m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.7B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.3B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
285.5B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
39.8B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
38.5B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
87.4T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.1B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 91% of companies in the United States of America
Percentile
9th
Based on 14 112 companies
9th percentile
-406.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Applied DNA Sciences Inc
Glance View

Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

BNBX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-406.1%
=
Operating Income
$-13.4m
/
Revenue
$3.3m
What is Applied DNA Sciences Inc's current Operating Margin?

The current Operating Margin for Applied DNA Sciences Inc is -406.1%, which is below its 3-year median of -239.3%.

How has Operating Margin changed over time?

Over the last 3 years, Applied DNA Sciences Inc’s Operating Margin has decreased from -74.6% to -406.1%. During this period, it reached a low of -439.2% on Jun 30, 2024 and a high of -54.1% on Dec 31, 2022.

Back to Top